125 results
Page 2 of 7
8-K
EX-99.1
2sfzxbu8
16 May 22
9 Meters Biopharma Provides Business Update and Reports Financial Results for First Quarter 2022
7:07am
8-K
3b66mf phj
13 Apr 22
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-99.2
aachbza9 uepv
23 Mar 22
9 Meters Biopharma Provides Business Update and Reports Financial Results
7:05am
8-K
EX-99.1
0nhfr
23 Mar 22
9 Meters Biopharma Provides Business Update and Reports Financial Results
7:05am
8-K
EX-99.1
qqc fbuql
28 Feb 22
9 Meters Biopharma Provides Clinical Update on Late-Stage Pipeline Products Vurolenatide for Short Bowel Syndrome and Larazotide for Celiac Disease
4:22pm
8-K
EX-99.2
v2b0m1 xf
15 Nov 21
9 Meters Biopharma Provides Business Update and Reports Financial Results for the Third Quarter 2021
7:34am
8-K
EX-99.1
zrd3wrw3fyapkfo56cq
26 Jul 21
Other Events
7:32am
8-K
EX-99.1
v5wdaaq
14 Jun 21
9 Meters Announces Initiation of Phase 2 VIBRANT Study of Vurolenatide for Short Bowel Syndrome
7:32am
8-K
EX-99.1
2lluf
19 Apr 21
9 Meters Biopharma, Inc. Announces Collaboration with the Duke Clinical Research Institute to Support 9 Meters’ Program in Short Bowel Syndrome
7:32am
8-K
EX-99.1
5yxwmi5m3m 58jmggjw7
12 Apr 21
9 Meters Biopharma, Inc. and Celiac Disease Foundation Announce Collaboration to Support Clinical Trial Enrollment in 9 Meters’ Phase 3 CeDLara Study
7:32am
8-K
EX-1.1
8obkyxvqtiwuac4dfy
5 Apr 21
9 Meters Biopharma Announces Proposed Public Offering of Common Stock
4:26pm